Department of Medicine
Michael Charlton, an expert in liver transplantation, liver disease, and viral hepatitis, is the director of the Center for Liver Diseases and co-director of the Transplantation Institute. He has particular expertise in the diagnosis, treatment, and management of nonalcoholic fatty liver disease (nonalcoholic steatohepatitis) and viral hepatitis. He has served as a principal investigator on grants and as a study section member for the National Institutes of Health, including studies of the pathophysiology of nonalcoholic fatty liver disease and viral hepatitis. He has published more than 200 manuscripts and is a lead investigator for national and international clinical trials in viral hepatitis and nonalcoholic fatty liver disease.
He has served as president of the International Liver Transplantation Society and has applied his expertise in editorial roles with leading liver disease and transplantation journals, including associate editor for Hepatology, Transplantation, American Journal of Transplantation, and Liver Transplantation. He was also a founding associate editor for Clinical Gastroenterology and Hepatology.
Charlton holds an MD from Charing Cross and Westminster Medical School, University of London, United Kingdom. Previously, he was a professor of medicine at the Mayo Clinic, where he also served as director of hepatology and medical director of liver transplantation. Most recently, he was the director of the Intermountain Transplant and Regenerative Medicine Center in Utah.